Caxton Associates (New York) Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Aptiv
APTV
|
+$172M |
| 2 |
Freeport-McMoran
FCX
|
+$166M |
| 3 |
Tesla
TSLA
|
+$92.7M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$27.5M |
| 5 |
Pfizer
PFE
|
+$25.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$79M |
| 2 |
United Rentals
URI
|
+$36.1M |
| 3 |
TSMC
TSM
|
+$35M |
| 4 |
Micron Technology
MU
|
+$20.8M |
| 5 |
Zebra Technologies
ZBRA
|
+$15.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 24.5% |
| 2 | Healthcare | 17.22% |
| 3 | Materials | 15.97% |
| 4 | Technology | 5.36% |
| 5 | Financials | 5.32% |
Similar funds
Caxton Associates (New York)'s Q1 2022 Portfolio in Review
As of Q1 2022, Caxton Associates (New York) held 776 positions worth $1.23B, up 25% from $982M the previous quarter. Its ten largest holdings account for 62% of the portfolio.
Caxton Associates (New York) deployed $266M of net new capital in Q1 2022, opening 234 new positions and adding to 119 existing holdings. Its largest new stake was Aptiv: 1,293,400 shares worth $155M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 24% of assets, up from 4.8% a quarter earlier, followed by Healthcare and Materials.
On the sell side, the largest reduction was Amazon, an estimated $7.44M trimmed.
- Caxton Associates (New York)'s largest Q1 2022 buy was Aptiv: 1,293,400 shares worth $155M.
- Caxton Associates (New York) added most to Tesla in Q1 2022, an estimated $92.7M increase.
- Caxton Associates (New York)'s biggest Q1 2022 reduction was Amazon, cutting an estimated $7.44M.
- Caxton Associates (New York) fully exited State Street SPDR S&P 500 ETF Trust in Q1 2022, selling an estimated $79M.
- Caxton Associates (New York)'s ten largest holdings make up 62% of its $1.23B portfolio in Q1 2022.
- Caxton Associates (New York) opened 234 new positions and closed 282 in Q1 2022.
- Caxton Associates (New York)'s portfolio value rose 25% quarter-over-quarter to $1.23B.
Based on Caxton Associates (New York)'s 13F filing for Q1 2022, filed 16 May 2022.